Cardiac alterations in cirrhosis:: reversibility after liver transplantation

被引:223
作者
Torregrosa, M
Aguadé, S
Dos, L
Segura, R
Gónzalez, A
Evangelista, A
Castell, J
Margarit, C
Esteban, R
Guardia, J
Genescà, J
机构
[1] Univ Autonoma Barcelona, Hosp Univ Val Hebron, Dept Internal Med, Liver Unit, Barcelona 08035, Spain
[2] Univ Autonoma Barcelona, Hosp Univ Val Hebron, Dept Nucl Med, Barcelona 08035, Spain
[3] Univ Autonoma Barcelona, Hosp Univ Val Hebron, Echocardiog Lab, Barcelona 08035, Spain
[4] Univ Autonoma Barcelona, Hosp Univ Val Hebron, Dept Biochem, Barcelona 08035, Spain
[5] Univ Autonoma Barcelona, Hosp Univ Val Hebron, Liver Transplantat Unit, Barcelona 08035, Spain
关键词
complications of cirrhosis; portal hypertension; transplantation; ascites; nuclear cardiology; cardiac alterations;
D O I
10.1016/j.jhep.2004.09.008
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background/Aims: Liver cirrhosis induces cardiac alterations. We aimed to define these alterations and assess their reversibility after transplantation. Methods: Cirrhotic patients (n = 40) and controls (n = 15) underwent echocardiography and stress ventriculography. Fifteen cirrhotics were reevaluated 6-12 months after transplantation. Results: Cirrhotics had higher left ventricular wall thickness (9.6 +/- 1.2 vs. 8.8 +/- 1.2 mm; P < 0.05) and ejection fraction (73 +/- 6 vs. 65 +/- 4 %, P < 0.001) than controls. Basal diastolic function was similar. During stress, cirrhotics presented lower increases of heart rate, left ventricular ejection fraction, stroke volume and cardiac index (P < 0.05 for all), and diastolic dysfunction with lower ventricular peak filling rate (P = 0.001). Exercise capacity was reduced (48 +/- 21 vs. 76 +/- 24 W; P < 0.001). Ascitic patients exhibited more diastolic dysfunction at rest and during stress compared to non-ascitic patients. Liver transplantation caused regression of ventricular wall thickness (10.2 +/- 1.3 vs. 9.5 +/- 1.2 mm; P < 0.05), improvement of diastolic function, and normalization of systolic response and exercise capacity during stress (significant increases in heart rate, ventricular ejection fraction, stroke volume and cardiac index; P < 0.05 for all). Conclusions: Cardiac alterations in cirrhosis present with mild increases in ventricular wall thickness, diastolic dysfunction that worsens with ascites and physical stress, and abnormal systolic response to stress limiting exercise capacity. Liver transplantation reverses these alterations. (C) 2004 Published by Elsevier B.V. on behalf of the European Association for the Study of the Liver.
引用
收藏
页码:68 / 74
页数:7
相关论文
共 31 条
[1]  
BOSCH J, 1992, GASTROENTEROL CLIN N, V21, P1
[2]   CARDIAC INDEX QUANTIFICATION BY DOPPLER ULTRASOUND IN PATIENTS WITHOUT LEFT-VENTRICULAR OUTFLOW TRACT ABNORMALITIES [J].
EVANGELISTA, A ;
GARCIADORADO, D ;
DELCASTILLO, HG ;
GONZALEZALUJAS, T ;
SOLERSOLER, J .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1995, 25 (03) :710-716
[3]   Management of Hepatorenal syndrome:: Another piece of the puzzle [J].
Ginés, P ;
Guevara, M .
HEPATOLOGY, 2004, 40 (01) :16-18
[4]   CARDIAC HEMODYNAMICS IN ALCOHOLIC PATIENTS WITH CHRONIC LIVER DISEASE AND A PRESYSTOLIC GALLOP [J].
GOULD, L ;
SHARIFF, M ;
ZAHIR, M ;
DILIETO, M .
JOURNAL OF CLINICAL INVESTIGATION, 1969, 48 (05) :860-&
[5]   EXERCISE-INDUCED LEFT-VENTRICULAR DYSFUNCTION IN ALCOHOLIC AND NONALCOHOLIC CIRRHOSIS [J].
GROSE, RD ;
NOLAN, J ;
DILLON, JF ;
ERRINGTON, M ;
HANNAN, WJ ;
BOUCHIER, IAD ;
HAYES, PC .
JOURNAL OF HEPATOLOGY, 1995, 22 (03) :326-332
[6]  
GROSSMAN W, 1990, CIRCULATION, V81, P1
[7]  
HALL EM, 1953, AM J PATHOL, V29, P993
[8]   Left ventricular hypertrophy in rats with biliary cirrhosis [J].
Inserte, J ;
Perelló, A ;
Agulló, L ;
Ruiz-Meana, M ;
Schlüter, KD ;
Escalona, N ;
Graupera, M ;
Bosch, J ;
Garcia-Dorado, D .
HEPATOLOGY, 2003, 38 (03) :589-598
[9]   CARDIAC-PERFORMANCE IN PATIENTS WITH ASYMPTOMATIC ALCOHOLIC CIRRHOSIS OF THE LIVER [J].
KELBAEK, H ;
ERIKSEN, J ;
BRYNJOLF, I ;
RABOEL, A ;
LUND, JO ;
MUNCK, O ;
BONNEVIE, O ;
GODTFREDSEN, J .
AMERICAN JOURNAL OF CARDIOLOGY, 1984, 54 (07) :852-855
[10]  
Kim S, 2000, PHARMACOL REV, V52, P11